These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 26935253

  • 1. Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics.
    Vidal-Jordana A, Sastre-Garriga J, Pérez-Miralles F, Pareto D, Rio J, Auger C, Tintoré M, Rovira A, Montalban X.
    J Neuroimaging; 2016 Sep; 26(5):532-8. PubMed ID: 26935253
    [Abstract] [Full Text] [Related]

  • 2. Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
    Sastre-Garriga J, Tur C, Pareto D, Vidal-Jordana A, Auger C, Río J, Huerga E, Tintoré M, Rovira A, Montalban X.
    Mult Scler; 2015 May; 21(6):749-56. PubMed ID: 25392330
    [Abstract] [Full Text] [Related]

  • 3. Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
    Rojas JI, Patrucco L, Miguez J, Besada C, Cristiano E.
    Neurol Res; 2014 Jul; 36(7):615-8. PubMed ID: 24620963
    [Abstract] [Full Text] [Related]

  • 4. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
    Khalid F, Tauhid S, Chua AS, Healy BC, Stankiewicz JM, Weiner HL, Bakshi R.
    Int J Neurosci; 2017 May; 127(5):396-403. PubMed ID: 27143245
    [Abstract] [Full Text] [Related]

  • 5. Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
    Vidal-Jordana A, Sastre-Garriga J, Pérez-Miralles F, Tur C, Tintoré M, Horga A, Auger C, Río J, Nos C, Edo MC, Arévalo MJ, Castilló J, Rovira A, Montalban X.
    Mult Scler; 2013 Aug; 19(9):1175-81. PubMed ID: 23319072
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.
    Rudick RA, Fisher E, Lee JC, Duda JT, Simon J.
    Mult Scler; 2000 Dec; 6(6):365-72. PubMed ID: 11212130
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
    Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B.
    Mult Scler; 2012 Aug; 18(8):1125-34. PubMed ID: 22194217
    [Abstract] [Full Text] [Related]

  • 13. Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment.
    Uher T, Benedict RH, Horakova D, Bergsland N, Dusankova JB, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R.
    J Neurol Sci; 2014 Dec 15; 347(1-2):229-34. PubMed ID: 25456460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early spinal cord pseudoatrophy in interferon-beta-treated multiple sclerosis.
    Matusche B, Litvin L, Schneider R, Bellenberg B, Mühlau M, Pongratz V, Berthele A, Groppa S, Muthuraman M, Zipp F, Paul F, Wiendl H, Meuth SG, Sämann P, Weber F, Linker RA, Kümpfel T, Gold R, Lukas C.
    Eur J Neurol; 2023 Feb 15; 30(2):453-462. PubMed ID: 36318271
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal associations between brain structural changes and fatigue in early MS.
    Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi AH, Spain R, Pelletier D, Waubant E.
    Mult Scler Relat Disord; 2016 Jan 15; 5():29-33. PubMed ID: 26856940
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A, Piattella MC, Pantano P, Di Legge S, Caramia F, Russo P, Lenzi GL, Pozzilli C.
    J Neurol; 2004 Apr 15; 251(4):432-9. PubMed ID: 15083288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.